GSK, influenza vaccine
5 Late-Stage mRNA Vaccines to Watch
The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the market for cancer, influenza and more.
British drugmaker GSK moves mRNA flu vaccine to late-stage trials
(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, and said it would now progress to late-stage clinical development.
GSK Announces Promising Data From Phase II Seasonal Influenza MRNA Vaccine Program
Thursday announced positive data from a phase II trial for its mRNA seasonal influenza vaccine programme. The study
GSK reports positive interim data from mRNA influenza vaccine trial
"GSK reports positive interim data from mRNA influenza vaccine trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on t
GSK's mRNA flu vaccine programme to proceed to late-stage trials
British drugmaker GSK on Thursday announced positive results from its mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, saying it would now progress to late-stage clinical development.
GSK, CureVac mRNA flu shot reaches late-stage studies
GSK (NYSE:GSK) on Thursday announced its decision to advance its messenger-RNA-based flu vaccine candidate developed with CureVac (NASDAQ:CVAC) into late-stage development following a positive Phase 2 readout.
Searching for a vaccine against an ancient scourge: Syphilis genetics study points to a potential target
Syphilis cases have surged worldwide, leaving public health officials scrounging for ways to stop the spread. Now, a large, ...
EurekAlert!9d
Vaccine adjuvants: From empirical to a more rational drug design
Vaccine adjuvants have evolved significantly since their inception, transitioning from empirical discovery to a more ...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
studyfinds4d
Scientists take final key step toward a hepatitis C vaccine
Scientists have identified the protein complex that gives the hepatitis C virus the ability to bind and infect cells.
EurekAlert!3d
Searching for a vaccine against an ancient scourge
Syphilis cases have surged worldwide, leaving public health officials scrounging for ways to stop the spread. Now, a large, collaborative study of syphilis genetics from four continents has found ...
News Medical on MSN2d
Collaborative study offers hope for syphilis vaccine development
Syphilis cases have surged worldwide, leaving public health officials scrounging for ways to stop the spread. Now, a large, collaborative study of syphilis genetics from four continents has found ...
GEN11d
Increasing Vaccine Efficacy with Novel Adjuvants
Derived from the Latin adjuvare (to help or aid), adjuvants enhance antigen-specific vaccine immunogenicity. Added only when ...
dvm36011d
Vaccine in development against deadly honeybee pathogen
DWV is primarily spread by Varroa destructor mites, which feed on the fat bodies of adult honey bees, as well as pupae.